This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Genetic variations in methotrexate metabolic pathway genes influence methotrexate responses in rheumatoid arthritis patients in Malaysia
Scientific Reports Open Access 13 July 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Dell JR et al. (1996) Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334: 1287–1291
O'Dell JR et al. (2000) Early sero-positive rheumatoid arthritis treatment: A 2-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 43: S382
Kloppenburg M et al. (1994) Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 37: 629–636
Tilley BC et al. (1995) Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med 122: 81–89
Greenwald RA (1995) Tetracyclines may be therapeutically beneficial in rheumatoid arthritis, but not for the reasons that you think. J Clin Rheumatol 3: 190–193
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Alarcón, G. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy. Nat Rev Rheumatol 2, 296–297 (2006). https://doi.org/10.1038/ncprheum0195
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0195